Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Rite Aid Corporation (RAD)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
5.41-0.31 (-5.42%)
At close: 04:00PM EDT
5.45 +0.04 (+0.74%)
After hours: 06:05PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Hammer

Hammer

Previous Close5.72
Open5.50
Bid5.45 x 1300
Ask5.46 x 800
Day's Range5.24 - 5.55
52 Week Range4.44 - 15.65
Volume2,725,132
Avg. Volume2,468,589
Market Cap300.941M
Beta (5Y Monthly)1.03
PE Ratio (TTM)N/A
EPS (TTM)-9.96
Earnings DateDec 19, 2022 - Dec 23, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 14, 1999
1y Target Est4.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RAD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rite Aid Corporation
    Analyst Report: Walgreens Boots Alliance, Inc.Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens’ core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
Advertisement
Advertisement